CRONOS GROUP INC. Proceeds from Sale and Maturity of Marketable Securities
CRONOS GROUP INC. (CRON) reported Proceeds from Sale and Maturity of Marketable Securities of $40.00 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Investing Activities
us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities · last filed 2026-08-06
- CRONOS GROUP INC. proceeds from sale and maturity of marketable securities for the quarter ending 2026-06-30 was $0.00.
- CRONOS GROUP INC. proceeds from sale and maturity of marketable securities for the quarter ending 2026-03-31 was $40.00M.
- CRONOS GROUP INC. proceeds from sale and maturity of marketable securities for the quarter ending 2025-12-31 was $0.00.
- CRONOS GROUP INC. proceeds from sale and maturity of marketable securities for the quarter ending 2025-09-30 was $0.00.
- CRONOS GROUP INC. proceeds from sale and maturity of marketable securities for fiscal 2025 was $0.00, a 100.00% decline from fiscal 2024.
- CRONOS GROUP INC. proceeds from sale and maturity of marketable securities for fiscal 2024 was $185.82M, a 65.13% decline from fiscal 2023.
- CRONOS GROUP INC. proceeds from sale and maturity of marketable securities for fiscal 2023 was $532.84M, a 98.18% increase from fiscal 2022.
- CRONOS GROUP INC. proceeds from sale and maturity of marketable securities for fiscal 2022 was $268.87M, a 24.88% increase from fiscal 2021.
| Period end | Proceeds from Sale and Maturity of Marketable Securities 3 month | Proceeds from Sale and Maturity of Marketable Securities 3 month as first filed | Proceeds from Sale and Maturity of Marketable Securities 6 month | Proceeds from Sale and Maturity of Marketable Securities 6 month as first filed | Proceeds from Sale and Maturity of Marketable Securities 9 month | Proceeds from Sale and Maturity of Marketable Securities 12 month | Proceeds from Sale and Maturity of Marketable Securities 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $40.00M 10-Q · filed 2026-08-06 | $40.00M derived: sum of 3 quarters · filed 2026-08-06 | $40.00M derived: sum of 4 quarters · filed 2026-08-06 | |||
| 2026-03-31 | $40.00M 10-Q · filed 2026-05-11 | $40.00M derived: sum of 2 quarters · filed 2026-05-11 | $40.00M derived: sum of 3 quarters · filed 2026-05-11 | $40.00M derived: sum of 4 quarters · filed 2026-08-06 | |||
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $0.00 derived: sum of 2 quarters · filed 2026-02-26 | $0.00 derived: sum of 3 quarters · filed 2026-08-06 | $0.00 10-K · filed 2026-02-26 | |||
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $0.00 derived: sum of 2 quarters · filed 2026-08-06 | $0.00 10-Q · filed 2025-11-06 | -$1.35M derived: sum of 4 quarters · filed 2026-08-06 | |||
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $0.00 10-Q · filed 2026-08-06 | -$1.35M derived: sum of 3 quarters · filed 2026-08-06 | -$1.63M derived: sum of 4 quarters · filed 2026-08-06 | |||
| 2025-03-31 | $0.00 10-Q · filed 2026-05-11 | -$1.35M derived: sum of 2 quarters · filed 2026-05-11 | -$1.63M derived: sum of 3 quarters · filed 2026-05-11 | -$3.06M derived: sum of 4 quarters · filed 2026-05-11 | |||
| 2024-12-31 | -$1.35M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$1.63M derived: sum of 2 quarters · filed 2026-02-26 | -$3.06M derived: sum of 3 quarters · filed 2026-02-26 | $185.82M 10-K · filed 2026-02-26 | |||
| 2024-09-30 | -$281.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$1.71M derived: sum of 2 quarters · filed 2025-11-06 | $187.17M 10-Q · filed 2025-11-06 | $339.24M derived: sum of 4 quarters · filed 2026-02-26 | |||
| 2024-06-30 | -$1.43M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $187.45M 10-Q · filed 2025-08-07 | $339.52M derived: sum of 3 quarters · filed 2026-02-26 | $550.87M derived: sum of 4 quarters · filed 2026-02-26 | |||
| 2024-03-31 | $188.87M 10-Q · filed 2025-05-08 | $340.94M derived: sum of 2 quarters · filed 2026-02-26 | $552.29M derived: sum of 3 quarters · filed 2026-02-26 | $608.36M derived: sum of 4 quarters · filed 2026-02-26 | |||
| 2023-12-31 | $152.07M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $363.42M derived: sum of 2 quarters · filed 2026-02-26 | $419.48M derived: sum of 3 quarters · filed 2026-02-26 | $532.84M 10-K · filed 2026-02-26 | |||
| 2023-09-30 | $211.35M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $267.41M derived: sum of 2 quarters · filed 2024-11-12 | $380.76M 10-Q · filed 2024-11-12 | $532.71M derived: sum of 4 quarters · filed 2025-02-27 | |||
| 2023-06-30 | $56.06M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $169.42M 10-Q · filed 2024-08-08 | $321.36M derived: sum of 3 quarters · filed 2025-02-27 | $320.31M derived: sum of 4 quarters · filed 2025-02-27 | |||
| 2023-03-31 | $113.36M 10-Q · filed 2024-05-09 | $265.30M derived: sum of 2 quarters · filed 2025-02-27 | $264.25M derived: sum of 3 quarters · filed 2025-02-27 | $382.23M derived: sum of 4 quarters · filed 2025-02-27 | |||
| 2022-12-31 | $151.94M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $150.90M derived: sum of 2 quarters · filed 2025-02-27 | $268.87M derived: sum of 3 quarters · filed 2025-02-27 | $268.87M 10-K · filed 2025-02-27 | |||
| 2022-09-30 | -$1.05M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $116.92M derived: sum of 2 quarters · filed 2023-11-08 | $116.92M 10-Q · filed 2023-11-08 | $196.43M derived: sum of 4 quarters · filed 2024-02-29 | |||
| 2022-06-30 | $117.97M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $117.97M 10-Q · filed 2023-08-08 | $197.48M derived: sum of 3 quarters · filed 2024-02-29 | $197.07M derived: sum of 4 quarters · filed 2024-02-29 | |||
| 2022-03-31 | $0.00 10-Q · filed 2023-05-09 | $79.50M derived: sum of 2 quarters · filed 2024-02-29 | $79.10M derived: sum of 3 quarters · filed 2024-02-29 | $215.30M derived: sum of 4 quarters · filed 2024-02-29 | |||
| 2021-12-31 | $79.50M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $79.10M derived: sum of 2 quarters · filed 2024-02-29 | $215.30M derived: sum of 3 quarters · filed 2024-02-29 | $215.30M 10-K · filed 2024-02-29 | |||
| 2021-09-30 | -$403.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-07 | $135.80M derived: sum of 2 quarters · filed 2022-11-07 | $135.80M 10-Q · filed 2022-11-07 | $212.47M derived: sum of 4 quarters · filed 2023-02-28 | |||
| 2021-06-30 | $136.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $136.20M 10-Q · filed 2022-08-09 | $212.88M derived: sum of 3 quarters · filed 2023-02-28 | $153.66M derived: sum of 4 quarters · filed 2023-02-28 | |||
| 2021-03-31 | $0.00 10-Q · filed 2021-05-07 | $76.67M derived: sum of 2 quarters · filed 2023-02-28 | $17.45M derived: sum of 3 quarters · filed 2023-02-28 | $216.40M derived: sum of 4 quarters · filed 2023-02-28 | |||
| 2020-12-31 | $76.67M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $17.45M derived: sum of 2 quarters · filed 2023-02-28 | $216.40M derived: sum of 3 quarters · filed 2023-02-28 | $296.73M 10-K · filed 2023-02-28 | $95.40M 10-K · filed 2021-02-26 | ||
| 2020-09-30 | -$59.22M derived: 10-Q 9 month − 10-Q/A 6 month · filed 2022-02-18 | $139.72M derived: sum of 2 quarters · filed 2022-02-18 | $220.06M 10-Q · filed 2022-02-18 | $220.06M derived: sum of 4 quarters · filed 2022-03-01 | |||
| 2020-06-30 | $198.94M derived: 10-Q/A 6 month − 10-Q 3 month · filed 2022-02-18 | $279.27M 10-Q/A · filed 2022-02-18 | $203.68M 10-Q · filed 2020-08-06 | $279.27M derived: sum of 3 quarters · filed 2022-03-01 | $279.27M derived: sum of 4 quarters · filed 2022-03-01 | ||
| 2020-03-31 | $80.33M 10-Q · filed 2021-05-07 | $206.85M 10-Q · filed 2020-05-08 | $80.33M derived: sum of 2 quarters · filed 2022-03-01 | $80.33M derived: sum of 3 quarters · filed 2022-03-01 | $80.33M derived: sum of 4 quarters · filed 2022-03-01 | ||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $0.00 derived: sum of 2 quarters · filed 2022-03-01 | $0.00 derived: sum of 3 quarters · filed 2022-03-01 | $0.00 10-K · filed 2022-03-01 | |||
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $0.00 derived: sum of 2 quarters · filed 2020-11-05 | $0.00 10-Q · filed 2020-11-05 | ||||
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $0.00 10-Q · filed 2020-08-06 | |||||
| 2019-03-31 | $0.00 10-Q · filed 2020-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |